Evaluation and management of acute high-grade immunotherapy-related neurotoxicity

Immune checkpoint inhibitor monoclonal antibodies allow the host's immune system to attack tumors, which has revolutionized cancer care over the last decade. As the use of immune checkpoint inhibitors has expanded, so have autoimmune-like complications known as immune-related adverse events. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandoval, Marcelo, Wechsler, Adriana H., Alhajji, Zahra, Viets-Upchurch, Jayne, Brock, Patricia, Lipe, Demis N., Al-breiki, Aisha, Yeung, Sai-Ching J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958505/
https://www.ncbi.nlm.nih.gov/pubmed/36851967
http://dx.doi.org/10.1016/j.heliyon.2023.e13725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958505/
https://www.ncbi.nlm.nih.gov/pubmed/36851967
http://dx.doi.org/10.1016/j.heliyon.2023.e13725

Ejemplares similares